Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Candel Therapeutics Inc (NQ: CADL )

3.510 -0.190 (-5.14%)
Streaming Delayed Price Updated: 1:04 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,514
Open 3.800
Bid (Size) 3.510 (2)
Ask (Size) 3.710 (3)
Prev. Close 3.700
Today's Range 3.500 - 3.800
52wk Range 3.330 - 14.78
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
71 Biggest Movers From Yesterday
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $... 
Via Benzinga

Performance

YTD
-56.12%
-56.12%
1 Month
-36.30%
-36.30%
3 Month
-18.94%
-18.94%
6 Month
-67.20%
-67.20%
1 Year
-49.86%
-49.86%

More News

Read More
54 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
Via Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Via Benzinga
Exposures Product Safety
32 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Kadmon Surges Following Acquisition News; UiPath Shares Drop
Via Benzinga
Topics Stocks
Exposures US Equities
50 Biggest Movers From Yesterday
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1%; REV Group Shares Plummet
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
72 Biggest Movers From Yesterday
Via Benzinga
30 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
54 Biggest Movers From Yesterday
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
Via Benzinga
72 Biggest Movers From Yesterday
Via Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
60 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Via Benzinga
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.